«Kallikreins

Below is an extended Kallikreins patents listing. Click here to return to the Kallikreins main in depth entry.

Patents :
US Patent No.	Title
6964868	Human genes and gene expression products II
7056937	Sulfonylquinoxalone derivatives as bradykinin antagonists
7064107	Prevention and reduction of blood loss
7074571	Serine carboxypeptidase hx (SCPhx) and compositions thereof
7074765	Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
7074783	Sulfonylbenzodiazepinone acetamides as bradykinin antagonists
7074901	Isolated human vCOL16A1 polypeptide and fragments thereof
7083987	Activity based probe analysis
7094548	Purification of recombinant proteins fused to multiple epitopes
7094587	16002 Molecules and uses therefor
7094876	Human cDNAs and proteins and uses thereof
7053042	Activation of peptide prodrugs by hK2
7041785	B.sub.1-bradykinin receptor antagonists and use thereof
7037667	Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
6984627	Peptide derivatives
6989262	Plasmin variants and uses thereof
6989369	Kunitz domain peptides
6991901	Proteins and nucleic acids encoding same
7005500	Human cDNAs and proteins and uses thereof
7019123	Human bikunin
7019194	SCCE modified transgenic mammals and their use as models of human disease
7022497	Human kallikrein-like genes
7029654	Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
7030110	Cyclic oxyguanidine pyrazinones as protease inhibitors
7098036	Antibodies to lipoproteins and apolipoproteins and methods of use thereof
7105172	Treatment of rosacea
7318921	Therapeutic compositions that alter the immune response
7329737	Antibodies that bind hK-1
7335355	Antimicrobial agent
7351566	27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor
7358261	Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
7361346	Therapeutic compositions that produce an immune response
7361634	Pain-sensitive therapeutic wound dressings
7371207	Estrogen receptor .alpha. regulated gene expression, related assays and therapeutics
7402586	Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
7410788	Compositions and methods for production of disulfide bond containing proteins in host cells
7291495	.beta.-Secretase variant
7276480	Prevention and reduction of blood loss
7267956	Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
7122629	Human cDNAs and proteins and uses thereof
7132264	Human serpin polypeptides
7141549	Proteins and nucleic acids encoding same
7153829	Kallikrein-inhibitor therapies
7166576	Methods for preserving organs and tissues
7183281	Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists
7195759	Therapeutic uses of glandular kallikrein
7199229	Kallikrein gene
7211566	Selective bradykinin (BK) B1 peptidic receptor antagonists and uses thereof
7235530	Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
7419783	Engineering of leader peptides for the secretion of recombinant proteins in bacteria

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.